Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer

Weill Cornell Medical College, New York

University of Rochester, Rochester

Allegheny Health Network Research Institute, Pittsburgh

Christiana Care Health Services, Newark

University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore

University of Virginia Health System, Charlottesville

Southeastern Medical Oncology Center, Clinton

Florida Cancer Specialists Sarasota Cattlemen, Sarasota

Vanderbilt University Medical Center, Nashville

Cleveland Clinic Foundation, Cleveland

Washington University School of Medicine, St Louis

University of Texas MD Anderson Cancer Center, Houston

University of The Texas Health Science Center at San Antonio, San Antonio

University of Southern California Medical Center, Los Angeles

Beverly Hills Cancer Center, Beverly Hills

Massachusetts General Hospital, Boston

The Valley Hospital, Ridgewood

Lifespan Cancer Institute, Providence

University Health Network - Princess Margaret Cancer Centre, Toronto

The Research Institute of the McGill University Health, Montreal

University Institute of Cardiology and Respirology of Quebec, Québec